Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Mar 2024 |
1,791 |
37,813
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Mar 2024 |
3,209 |
12,837
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Mar 2024 |
2,500 |
4,677
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 318.96 per share. |
08 Mar 2024 |
100 |
42,604
(0%)
|
0%
|
319.0 |
31,896
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 318.33 per share. |
08 Mar 2024 |
4,900 |
42,704
(0%)
|
0%
|
318.3 |
1,559,817
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.97 per share. |
08 Mar 2024 |
1,791 |
47,604
(0%)
|
0%
|
112.0 |
200,538
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. |
08 Mar 2024 |
3,209 |
45,813
(0%)
|
0%
|
131.6 |
422,433
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
08 Mar 2024 |
2,500 |
42,604
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Steven M. Paul
|
Director |
Other type of transaction at price $ 315.18 per share. |
29 Feb 2024 |
47,378 |
70,608
(0%)
|
0%
|
315.2 |
14,932,598
|
Common Stock |
Steven M. Paul
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Feb 2024 |
30,304 |
30,304
(0%)
|
0%
|
|
0
|
Common Stock |
Steven M. Paul
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Feb 2024 |
30,304 |
2,364
(0%)
|
0%
|
|
0
|
Common Stock |
Steven M. Paul
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Feb 2024 |
30,304 |
32,668
(0%)
|
0%
|
|
0
|
Common Stock |
Steven M. Paul
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Feb 2024 |
30,304 |
10,000
(0%)
|
0%
|
|
0
|
Common Stock |
Steven M. Paul
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Feb 2024 |
30,304 |
30,304
(0%)
|
0%
|
|
0
|
Common Stock |
Steven M. Paul
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Feb 2024 |
30,304 |
40,304
(0%)
|
0%
|
|
0
|
Common Stock |
Paul M. Steven
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 Feb 2024 |
27,510 |
757,045
|
-
|
|
-
|
Option (right to buy) |
Steven Paul M.
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 99.72 per share. |
23 Feb 2024 |
4,008 |
42,114
(0%)
|
0%
|
99.7 |
399,678
|
Common Stock |
Steven M. Paul
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
23 Feb 2024 |
27,510 |
38,106
(0%)
|
0%
|
7.3 |
199,998
|
Common Stock |
Paul M. Steven
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 Feb 2024 |
4,008 |
135,992
|
-
|
|
-
|
Option (right to buy) |
Meury William
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2024 |
38,688 |
38,688
|
-
|
|
-
|
Restricted Stock Units |
Brown Jason
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2024 |
10,306 |
10,306
|
-
|
|
-
|
Restricted Stock Units |
Andrew Miller
|
President of R&D |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2024 |
15,855 |
15,855
|
-
|
|
-
|
Restricted Stock Units |
Brannan Stephen
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2024 |
10,306 |
10,306
|
-
|
|
-
|
Restricted Stock Units |
Brown Jason
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 318.00 per share. |
13 Feb 2024 |
278 |
21,167
(0%)
|
0%
|
318 |
88,404
|
Common Stock |
William P. Kane
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2024 |
10,306 |
10,306
|
-
|
|
-
|
Restricted Stock Units |
Miller Andrew
|
President of R&D |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 317.14 per share. |
09 Feb 2024 |
1,011 |
23,389
(0%)
|
0%
|
317.1 |
320,629
|
Common Stock |
Paul Steven M.
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 317.14 per share. |
09 Feb 2024 |
804 |
10,596
(0%)
|
0%
|
317.1 |
254,981
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Feb 2024 |
2,500 |
7,177
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 316.05 per share. |
08 Feb 2024 |
4,182 |
41,968
(0%)
|
0%
|
316.0 |
1,321,721
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.97 per share. |
08 Feb 2024 |
5,000 |
46,150
(0%)
|
0%
|
112.0 |
559,850
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Feb 2024 |
5,000 |
39,604
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 316.56 per share. |
08 Feb 2024 |
818 |
41,150
(0%)
|
0%
|
316.6 |
258,946
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 317.14 per share. |
08 Feb 2024 |
1,046 |
40,104
(0%)
|
0%
|
317.1 |
331,728
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
08 Feb 2024 |
2,500 |
41,150
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. |
08 Jan 2024 |
5,304 |
43,954
(0%)
|
0%
|
131.6 |
698,219
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.97 per share. |
08 Jan 2024 |
9,696 |
53,650
(0%)
|
0%
|
112.0 |
1,085,661
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jan 2024 |
5,304 |
16,046
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jan 2024 |
9,696 |
44,604
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
08 Jan 2024 |
2,500 |
38,650
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jan 2024 |
2,500 |
9,677
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 316.81 per share. |
08 Jan 2024 |
15,000 |
38,650
(0%)
|
0%
|
316.8 |
4,752,150
|
Common Stock |
P. Kane William
|
Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 316.30 per share. |
28 Dec 2023 |
3,828 |
13,828
(0%)
|
0%
|
316.3 |
1,210,796
|
Common Stock |
Meury William
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 316.30 per share. |
28 Dec 2023 |
8,694 |
29,379
(0%)
|
0%
|
316.3 |
2,749,912
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. |
08 Dec 2023 |
10,000 |
46,150
(0%)
|
0%
|
131.6 |
1,316,400
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 204.18 per share. |
08 Dec 2023 |
99 |
36,150
(0%)
|
0%
|
204.2 |
20,214
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 200.11 per share. |
08 Dec 2023 |
1,565 |
44,585
(0%)
|
0%
|
200.1 |
313,172
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
08 Dec 2023 |
2,500 |
36,150
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Dec 2023 |
10,000 |
21,350
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 201.73 per share. |
08 Dec 2023 |
2,116 |
42,469
(0%)
|
0%
|
201.7 |
426,861
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Dec 2023 |
2,500 |
12,177
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 203.80 per share. |
08 Dec 2023 |
2,251 |
36,249
(0%)
|
0%
|
203.8 |
458,754
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 202.74 per share. |
08 Dec 2023 |
3,969 |
38,500
(0%)
|
0%
|
202.7 |
804,675
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 177.14 per share. |
08 Nov 2023 |
265 |
36,703
(0%)
|
0%
|
177.1 |
46,942
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. |
08 Nov 2023 |
5,000 |
38,650
(0%)
|
0%
|
131.6 |
658,200
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 178.90 per share. |
08 Nov 2023 |
808 |
35,895
(0%)
|
0%
|
178.9 |
144,551
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
08 Nov 2023 |
2,500 |
33,650
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Nov 2023 |
2,500 |
14,677
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 175.69 per share. |
08 Nov 2023 |
401 |
36,968
(0%)
|
0%
|
175.7 |
70,452
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Nov 2023 |
5,000 |
31,350
|
-
|
|
-
|
Option (right to buy) |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 180.08 per share. |
08 Nov 2023 |
2,245 |
33,650
(0%)
|
0%
|
180.1 |
404,280
|
Common Stock |
Brannan Stephen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 174.11 per share. |
08 Nov 2023 |
1,281 |
37,369
(0%)
|
0%
|
174.1 |
223,035
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 175.59 per share. |
22 Aug 2023 |
505 |
30,547
(0%)
|
0%
|
175.6 |
88,673
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 174.88 per share. |
22 Aug 2023 |
855 |
31,052
(0%)
|
0%
|
174.9 |
149,522
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 173.64 per share. |
22 Aug 2023 |
80 |
31,907
(0%)
|
0%
|
173.6 |
13,891
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 176.60 per share. |
22 Aug 2023 |
60 |
30,487
(0%)
|
0%
|
176.6 |
10,596
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Aug 2023 |
1,500 |
93,226
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
22 Aug 2023 |
1,500 |
31,987
(0%)
|
0%
|
9.2 |
13,800
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
08 Aug 2023 |
2,500 |
26,150
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.64 per share. |
08 Aug 2023 |
5,000 |
31,150
(0%)
|
0%
|
131.6 |
658,200
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Aug 2023 |
5,000 |
46,350
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Aug 2023 |
2,500 |
22,177
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 181.50 per share. |
08 Aug 2023 |
1,250 |
26,150
(0%)
|
0%
|
181.5 |
226,875
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 180.93 per share. |
08 Aug 2023 |
1,355 |
27,400
(0%)
|
0%
|
180.9 |
245,160
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 179.53 per share. |
08 Aug 2023 |
2,395 |
28,755
(0%)
|
0%
|
179.5 |
429,974
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 194.78 per share. |
01 Aug 2023 |
3,399 |
11,401
(0%)
|
0%
|
194.8 |
662,057
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Aug 2023 |
13,810 |
33,702
|
-
|
|
-
|
Option (right to buy) |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 198.41 per share. |
01 Aug 2023 |
600 |
990
(0%)
|
0%
|
198.4 |
119,046
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 197.66 per share. |
01 Aug 2023 |
400 |
1,590
(0%)
|
0%
|
197.7 |
79,064
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 196.59 per share. |
01 Aug 2023 |
3,110 |
1,990
(0%)
|
0%
|
196.6 |
611,395
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 195.61 per share. |
01 Aug 2023 |
6,301 |
5,100
(0%)
|
0%
|
195.6 |
1,232,539
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
01 Aug 2023 |
13,810 |
14,800
(0%)
|
0%
|
7.3 |
100,399
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jul 2023 |
13,810 |
47,512
|
-
|
|
-
|
Option (right to buy) |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 216.78 per share. |
03 Jul 2023 |
3,201 |
3,399
(0%)
|
0%
|
216.8 |
693,913
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 215.91 per share. |
03 Jul 2023 |
7,966 |
6,600
(0%)
|
0%
|
215.9 |
1,719,939
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 214.61 per share. |
03 Jul 2023 |
234 |
14,566
(0%)
|
0%
|
214.6 |
50,219
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
03 Jul 2023 |
13,810 |
14,800
(0%)
|
0%
|
7.3 |
100,399
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Sale of securities on an exchange or to another person at price $ 217.82 per share. |
03 Jul 2023 |
2,409 |
990
(0%)
|
0%
|
217.8 |
524,728
|
Common Stock |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 216.03 per share. |
03 Jul 2023 |
400 |
990
(0%)
|
0%
|
216.0 |
86,412
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jul 2023 |
1,000 |
13,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 215.40 per share. |
03 Jul 2023 |
600 |
1,390
(0%)
|
0%
|
215.4 |
129,240
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
03 Jul 2023 |
1,000 |
1,990
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
990
(0%)
|
0%
|
|
0
|
Common Stock |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
Jeffrey M. Jonas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
990
(0%)
|
0%
|
|
0
|
Common Stock |
Jeffrey M. Jonas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
James I. Healy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
33,490
(0%)
|
0%
|
|
0
|
Common Stock |
James I. Healy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
990
(0%)
|
0%
|
|
0
|
Common Stock |
Laurie J. Olson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
990
(0%)
|
0%
|
|
0
|
Common Stock |
David E. Wheadon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
David E. Wheadon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
990
(0%)
|
0%
|
|
0
|
Common Stock |
Denice M. Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
1,904 |
1,904
|
-
|
|
-
|
Option (right to buy) |
Denice M. Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2023 |
990 |
990
(0%)
|
0%
|
|
0
|
Common Stock |
James I. Healy
|
Director |
Other type of transaction at price $ 0.00 per share. |
14 Jun 2023 |
400,000 |
1,372,441
(5%)
|
1%
|
|
0
|
Common Stock |
James I. Healy
|
Director |
Other type of transaction at price $ 0.00 per share. |
14 Jun 2023 |
8,025 |
8,025
(0%)
|
0%
|
|
0
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 223.21 per share. |
23 May 2023 |
3,309 |
33,361
(0%)
|
0%
|
223.2 |
738,602
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 May 2023 |
9,000 |
94,726
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 225.93 per share. |
23 May 2023 |
782 |
30,487
(0%)
|
0%
|
225.9 |
176,677
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 225.19 per share. |
23 May 2023 |
1,022 |
31,269
(0%)
|
0%
|
225.2 |
230,144
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 224.19 per share. |
23 May 2023 |
1,070 |
32,291
(0%)
|
0%
|
224.2 |
239,883
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 221.28 per share. |
23 May 2023 |
724 |
38,763
(0%)
|
0%
|
221.3 |
160,207
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
23 May 2023 |
9,000 |
39,487
(0%)
|
0%
|
9.2 |
82,800
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 222.24 per share. |
23 May 2023 |
2,093 |
36,670
(0%)
|
0%
|
222.2 |
465,148
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Apr 2023 |
30,000 |
240,492
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
18 Apr 2023 |
30,000 |
60,900
(0%)
|
0%
|
9.2 |
276,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 200.16 per share. |
18 Apr 2023 |
30,000 |
30,900
(0%)
|
0%
|
200.2 |
6,004,800
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
18 Apr 2023 |
8,500 |
39,400
(0%)
|
0%
|
9.2 |
78,200
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 200.13 per share. |
18 Apr 2023 |
15,000 |
24,400
(0%)
|
0%
|
200.1 |
3,001,950
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Apr 2023 |
8,500 |
231,992
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Apr 2023 |
5,000 |
28,650
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 176.88 per share. |
10 Apr 2023 |
5,000 |
23,650
(0%)
|
0%
|
176.9 |
884,400
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Apr 2023 |
5,000 |
6,362
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
03 Apr 2023 |
1,000 |
1,000
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Apr 2023 |
1,000 |
14,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 181.02 per share. |
03 Apr 2023 |
1,000 |
0
(0%)
|
0%
|
181.0 |
181,020
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 189.51 per share. |
09 Mar 2023 |
5,000 |
23,650
(0%)
|
0%
|
189.5 |
947,550
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Mar 2023 |
5,000 |
24,677
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
09 Mar 2023 |
5,000 |
28,650
(0%)
|
0%
|
5.5 |
27,250
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 190.01 per share. |
21 Feb 2023 |
6,000 |
30,487
(0%)
|
0%
|
190.0 |
1,140,060
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Feb 2023 |
6,000 |
103,726
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
21 Feb 2023 |
6,000 |
36,487
(0%)
|
0%
|
9.2 |
55,200
|
Common Stock |
Steve M. Paul
|
Director, CSO and President of R&D |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
22,800 |
22,800
|
-
|
|
-
|
Option (Right to Buy) |
Steve M. Paul
|
Director, CSO and President of R&D |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
11,400 |
11,400
(0%)
|
0%
|
|
0
|
Common Stock |
Steve M. Paul
|
Director, CSO and President of R&D |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Feb 2023 |
106,485 |
106,485
(0%)
|
0%
|
|
0
|
Common Stock |
Steve M. Paul
|
Director, CSO and President of R&D |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Feb 2023 |
106,485 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Steve M. Paul
|
Director, CSO and President of R&D |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Feb 2023 |
106,485 |
106,485
(0%)
|
0%
|
|
0
|
Common Stock |
Steve M. Paul
|
Director, CSO and President of R&D |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Feb 2023 |
106,485 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
8,650 |
30,487
(0%)
|
0%
|
|
0
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
17,350 |
17,350
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
12,550 |
30,900
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
25,100 |
25,100
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
09 Feb 2023 |
5,000 |
20,000
(0%)
|
0%
|
5.5 |
27,250
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
17,350 |
17,350
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2023 |
5,000 |
29,677
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
8,650 |
23,650
(0%)
|
0%
|
|
0
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 192.37 per share. |
09 Feb 2023 |
5,000 |
15,000
(0%)
|
0%
|
192.4 |
961,850
|
Common Stock |
William P. Kane
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2023 |
17,656 |
17,656
(0%)
|
0%
|
|
0
|
Common Stock |
William P. Kane
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Feb 2023 |
29,937 |
29,937
|
-
|
|
-
|
Stock Option (Right to Buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Jan 2023 |
817 |
109,926
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 200.14 per share. |
17 Jan 2023 |
200 |
21,837
(0%)
|
0%
|
200.1 |
40,028
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
17 Jan 2023 |
200 |
22,037
(0%)
|
0%
|
9.2 |
1,840
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
17 Jan 2023 |
817 |
22,654
(0%)
|
0%
|
9.2 |
7,516
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 201.41 per share. |
17 Jan 2023 |
817 |
21,837
(0%)
|
0%
|
201.4 |
164,552
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Jan 2023 |
200 |
109,726
|
-
|
|
-
|
Option (right to buy) |
James I. Healy
|
Director |
Other type of transaction at price $ 0.00 per share. |
12 Jan 2023 |
300,000 |
1,772,441
(6%)
|
1%
|
|
0
|
Common Stock |
James I. Healy
|
Director |
Sale of securities on an exchange or to another person at price $ 199.90 per share. |
12 Jan 2023 |
6,027 |
0
(0%)
|
0%
|
199.9 |
1,204,771
|
Common Stock |
James I. Healy
|
Director |
Other type of transaction at price $ 0.00 per share. |
12 Jan 2023 |
6,027 |
6,027
(0%)
|
0%
|
|
0
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 197.52 per share. |
09 Jan 2023 |
1,527 |
15,000
(0%)
|
0%
|
197.5 |
301,613
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jan 2023 |
3,473 |
0
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jan 2023 |
1,527 |
34,677
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 197.52 per share. |
09 Jan 2023 |
3,473 |
15,000
(0%)
|
0%
|
197.5 |
685,987
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
09 Jan 2023 |
3,473 |
18,473
(0%)
|
0%
|
7.3 |
25,249
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
09 Jan 2023 |
1,527 |
16,527
(0%)
|
0%
|
5.4 |
8,322
|
Common Stock |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2023 |
407 |
407
|
-
|
|
-
|
Option (right to buy) |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2023 |
181 |
181
|
-
|
|
-
|
Option (right to buy) |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2023 |
67 |
67
|
-
|
|
-
|
Option (right to buy) |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2023 |
321 |
321
|
-
|
|
-
|
Option (right to buy) |
William Meury
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2023 |
63,065 |
63,065
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Meury
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2023 |
38,073 |
38,073
(0%)
|
0%
|
|
0
|
Common Stock |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 197.48 per share. |
03 Jan 2023 |
1,000 |
0
(0%)
|
0%
|
197.5 |
197,480
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
03 Jan 2023 |
1,000 |
1,000
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jan 2023 |
1,000 |
15,000
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2022 |
7,100 |
47,817
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
21 Dec 2022 |
7,100 |
18,350
(0%)
|
0%
|
2.9 |
20,732
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Dec 2022 |
371 |
8,559
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Dec 2022 |
10,869 |
110,743
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
16 Dec 2022 |
627 |
21,837
(0%)
|
0%
|
9.2 |
5,768
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
16 Dec 2022 |
10,869 |
20,839
(0%)
|
0%
|
9.2 |
99,995
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
16 Dec 2022 |
371 |
21,210
(0%)
|
0%
|
9.2 |
3,413
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Dec 2022 |
627 |
626
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 200.76 per share. |
09 Dec 2022 |
3,637 |
15,000
(0%)
|
0%
|
200.8 |
730,164
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2022 |
1,363 |
11,362
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2022 |
3,637 |
3,473
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 200.76 per share. |
09 Dec 2022 |
1,363 |
15,000
(0%)
|
0%
|
200.8 |
273,636
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
09 Dec 2022 |
1,363 |
16,363
(0%)
|
0%
|
9.2 |
12,540
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
09 Dec 2022 |
3,637 |
18,637
(0%)
|
0%
|
7.3 |
26,441
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
01 Dec 2022 |
500 |
26,250
(0%)
|
0%
|
2.9 |
1,460
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2022 |
500 |
54,917
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2022 |
250 |
11,578
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 228.30 per share. |
01 Dec 2022 |
15,000 |
11,250
(0%)
|
0%
|
228.3 |
3,424,500
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
01 Dec 2022 |
250 |
25,750
(0%)
|
0%
|
7.3 |
1,818
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 225.85 per share. |
15 Nov 2022 |
16,500 |
9,970
(0%)
|
0%
|
225.9 |
3,726,525
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Nov 2022 |
16,500 |
121,612
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
15 Nov 2022 |
16,500 |
26,470
(0%)
|
0%
|
9.2 |
151,800
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
10 Nov 2022 |
1,000 |
40,500
(0%)
|
0%
|
2.9 |
2,920
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Nov 2022 |
1,000 |
55,417
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Nov 2022 |
1,000 |
11,828
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 225.98 per share. |
10 Nov 2022 |
15,000 |
25,500
(0%)
|
0%
|
226.0 |
3,389,700
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
10 Nov 2022 |
1,000 |
39,500
(0%)
|
0%
|
7.3 |
7,270
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 216.00 per share. |
09 Nov 2022 |
5,000 |
15,000
(0%)
|
0%
|
216 |
1,080,000
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2022 |
5,000 |
12,725
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
09 Nov 2022 |
5,000 |
20,000
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
01 Nov 2022 |
2,000 |
53,500
(0%)
|
0%
|
2.9 |
5,840
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2022 |
2,000 |
56,417
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 225.08 per share. |
01 Nov 2022 |
15,000 |
38,500
(0%)
|
0%
|
225.1 |
3,376,200
|
Common Stock |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 205.63 per share. |
11 Oct 2022 |
1,000 |
0
(0%)
|
0%
|
205.6 |
205,630
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
11 Oct 2022 |
1,000 |
1,000
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Oct 2022 |
1,000 |
16,000
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Oct 2022 |
5,000 |
17,725
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 207.51 per share. |
10 Oct 2022 |
5,000 |
15,000
(0%)
|
0%
|
207.5 |
1,037,550
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Oct 2022 |
5,000 |
20,000
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 230.48 per share. |
30 Sep 2022 |
33 |
14,470
(0%)
|
0%
|
230.5 |
7,606
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 228.74 per share. |
30 Sep 2022 |
2,819 |
19,692
(0%)
|
0%
|
228.7 |
644,818
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 229.77 per share. |
30 Sep 2022 |
5,189 |
14,503
(0%)
|
0%
|
229.8 |
1,192,277
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 227.05 per share. |
30 Sep 2022 |
2,459 |
22,511
(0%)
|
0%
|
227.1 |
558,316
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 233.20 per share. |
30 Sep 2022 |
400 |
9,970
(0%)
|
0%
|
233.2 |
93,280
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 232.00 per share. |
30 Sep 2022 |
1,100 |
10,370
(0%)
|
0%
|
232 |
255,200
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 231.30 per share. |
30 Sep 2022 |
2,000 |
11,470
(0%)
|
0%
|
231.3 |
462,600
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 230.02 per share. |
30 Sep 2022 |
1,000 |
13,470
(0%)
|
0%
|
230.0 |
230,020
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 243.46 per share. |
09 Sep 2022 |
5,000 |
15,000
(0%)
|
0%
|
243.5 |
1,217,300
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
09 Sep 2022 |
5,000 |
20,000
(0%)
|
0%
|
7.3 |
36,350
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Sep 2022 |
5,000 |
7,110
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Aug 2022 |
1,000 |
17,000
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 227.83 per share. |
09 Aug 2022 |
16,500 |
24,970
(0%)
|
0%
|
227.8 |
3,759,195
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2022 |
16,500 |
138,112
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
09 Aug 2022 |
16,500 |
41,470
(0%)
|
0%
|
9.2 |
151,800
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2022 |
5,703 |
19,143
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 228.05 per share. |
09 Aug 2022 |
12,264 |
15,000
(0%)
|
0%
|
228.0 |
2,796,805
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
09 Aug 2022 |
12,264 |
27,264
(0%)
|
0%
|
9.2 |
112,829
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 228.13 per share. |
09 Aug 2022 |
7,033 |
15,000
(0%)
|
0%
|
228.1 |
1,604,438
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
09 Aug 2022 |
7,033 |
22,033
(0%)
|
0%
|
7.3 |
51,130
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 228.10 per share. |
09 Aug 2022 |
5,703 |
15,000
(0%)
|
0%
|
228.1 |
1,300,854
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
09 Aug 2022 |
5,703 |
20,703
(0%)
|
0%
|
7.3 |
41,461
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2022 |
12,264 |
22,725
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2022 |
7,033 |
12,110
|
-
|
|
-
|
Option (right to buy) |
James I. Healy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
05 Aug 2022 |
32,500 |
32,500
(0%)
|
0%
|
16 |
520,000
|
Common Stock |
James I. Healy
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Aug 2022 |
32,500 |
0
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Jul 2022 |
15,000 |
34,989
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
11 Jul 2022 |
15,000 |
30,000
(0%)
|
0%
|
9.2 |
138,000
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 133.29 per share. |
11 Jul 2022 |
15,000 |
15,000
(0%)
|
0%
|
133.3 |
1,999,350
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 123.39 per share. |
29 Jun 2022 |
24,161 |
2,072,441
(7%)
|
0%
|
123.4 |
2,981,226
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 122.27 per share. |
29 Jun 2022 |
48,062 |
2,048,280
(7%)
|
0%
|
122.3 |
5,876,541
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 125.00 per share. |
29 Jun 2022 |
9,129 |
2,000,218
(7%)
|
0%
|
125 |
1,141,125
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 124.73 per share. |
29 Jun 2022 |
6,832 |
1,991,089
(7%)
|
0%
|
124.7 |
852,155
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 122.95 per share. |
29 Jun 2022 |
4,039 |
1,984,257
(7%)
|
0%
|
122.9 |
496,595
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 121.99 per share. |
29 Jun 2022 |
27,777 |
1,980,218
(7%)
|
0%
|
122.0 |
3,388,516
|
Common Stock |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
Jeffrey M. Jonas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
James I. Healy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
David E. Wheadon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
Denice M. Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 110.90 per share. |
09 Jun 2022 |
5,000 |
15,000
(0%)
|
0%
|
110.9 |
554,500
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2022 |
5,000 |
49,989
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
09 Jun 2022 |
5,000 |
20,000
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 110.00 per share. |
27 May 2022 |
1,000 |
0
(0%)
|
0%
|
110 |
110,000
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 May 2022 |
1,000 |
18,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
27 May 2022 |
1,000 |
1,000
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 104.10 per share. |
09 May 2022 |
5,000 |
15,000
(0%)
|
0%
|
104.1 |
520,500
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2022 |
5,000 |
54,989
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
09 May 2022 |
5,000 |
20,000
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Apr 2022 |
40 |
154,612
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Apr 2022 |
704 |
154,652
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Apr 2022 |
3,500 |
155,356
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 134.45 per share. |
19 Apr 2022 |
40 |
24,970
(0%)
|
0%
|
134.5 |
5,378
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
19 Apr 2022 |
40 |
25,010
(0%)
|
0%
|
9.2 |
368
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 133.20 per share. |
19 Apr 2022 |
704 |
24,970
(0%)
|
0%
|
133.2 |
93,773
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
19 Apr 2022 |
704 |
25,674
(0%)
|
0%
|
9.2 |
6,477
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 130.81 per share. |
19 Apr 2022 |
3,500 |
24,970
(0%)
|
0%
|
130.8 |
457,835
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
19 Apr 2022 |
3,500 |
28,470
(0%)
|
0%
|
9.2 |
32,200
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 129.38 per share. |
01 Apr 2022 |
47 |
683
(0%)
|
0%
|
129.4 |
6,081
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2022 |
2,500 |
36,204
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 128.45 per share. |
01 Apr 2022 |
7,728 |
15,000
(0%)
|
0%
|
128.5 |
992,662
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
01 Apr 2022 |
7,728 |
22,728
(0%)
|
0%
|
7.3 |
56,183
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2022 |
7,728 |
24,846
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
01 Apr 2022 |
2,500 |
15,000
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
01 Mar 2022 |
7,728 |
20,228
(0%)
|
0%
|
9.2 |
71,098
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2022 |
7,728 |
59,989
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2022 |
2,500 |
38,704
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 107.38 per share. |
01 Mar 2022 |
7,728 |
12,500
(0%)
|
0%
|
107.4 |
829,833
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
01 Mar 2022 |
2,500 |
12,500
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Steve M. Paul
|
Director, President CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2022 |
146,900 |
146,900
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2022 |
73,250 |
73,250
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2022 |
54,300 |
54,300
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
15 Feb 2022 |
1,000 |
1,000
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Feb 2022 |
1,000 |
19,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 110.00 per share. |
15 Feb 2022 |
1,000 |
0
(0%)
|
0%
|
110 |
110,000
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
48,500 |
48,500
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Feb 2022 |
1,500 |
158,856
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 111.14 per share. |
15 Feb 2022 |
1,500 |
24,970
(0%)
|
0%
|
111.1 |
166,710
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
15 Feb 2022 |
1,500 |
26,470
(0%)
|
0%
|
9.2 |
13,800
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Feb 2022 |
2,500 |
0
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Feb 2022 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 110.80 per share. |
01 Feb 2022 |
2,500 |
0
(0%)
|
0%
|
110.8 |
277,000
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Feb 2022 |
7,728 |
32,574
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 110.05 per share. |
01 Feb 2022 |
7,728 |
10,000
(0%)
|
0%
|
110.0 |
850,466
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
01 Feb 2022 |
7,728 |
17,728
(0%)
|
0%
|
7.3 |
56,183
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
01 Feb 2022 |
2,500 |
10,000
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Feb 2022 |
2,500 |
41,204
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jan 2022 |
2,500 |
2,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
03 Jan 2022 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 130.44 per share. |
03 Jan 2022 |
2,500 |
0
(0%)
|
0%
|
130.4 |
326,100
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2021 |
5,869 |
160,356
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
21 Dec 2021 |
1,101 |
24,970
(0%)
|
0%
|
9.2 |
10,129
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
21 Dec 2021 |
5,869 |
23,869
(0%)
|
0%
|
9.2 |
53,995
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2021 |
1,101 |
8,930
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 127.73 per share. |
01 Dec 2021 |
2,500 |
0
(0%)
|
0%
|
127.7 |
319,325
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2021 |
2,500 |
5,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Dec 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 127.57 per share. |
01 Dec 2021 |
7,728 |
20,000
(0%)
|
0%
|
127.6 |
985,861
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
01 Dec 2021 |
7,728 |
27,728
(0%)
|
0%
|
7.3 |
56,183
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
01 Dec 2021 |
2,500 |
20,000
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2021 |
2,500 |
46,204
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2021 |
7,728 |
40,302
|
-
|
|
-
|
Option (right to buy) |
Charmaine Lykins
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Nov 2021 |
75,000 |
75,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 138.24 per share. |
15 Nov 2021 |
1,000 |
0
(0%)
|
0%
|
138.2 |
138,240
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Nov 2021 |
1,000 |
20,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
15 Nov 2021 |
1,000 |
1,000
(0%)
|
0%
|
84.9 |
84,860
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 152.32 per share. |
08 Nov 2021 |
13,500 |
18,000
(0%)
|
0%
|
152.3 |
2,056,320
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Nov 2021 |
13,500 |
166,225
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
08 Nov 2021 |
13,500 |
31,500
(0%)
|
0%
|
9.2 |
124,200
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 136.67 per share. |
01 Nov 2021 |
2,500 |
0
(0%)
|
0%
|
136.7 |
341,675
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
2,500 |
7,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Nov 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
01 Nov 2021 |
26,500 |
54,327
(0%)
|
0%
|
2.9 |
77,380
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
26,500 |
58,417
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 144.54 per share. |
01 Nov 2021 |
300 |
51,500
(0%)
|
0%
|
144.5 |
43,362
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 143.78 per share. |
01 Nov 2021 |
740 |
51,800
(0%)
|
0%
|
143.8 |
106,397
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 142.14 per share. |
01 Nov 2021 |
787 |
52,540
(0%)
|
0%
|
142.1 |
111,864
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 140.74 per share. |
01 Nov 2021 |
400 |
53,327
(0%)
|
0%
|
140.7 |
56,296
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 139.87 per share. |
01 Nov 2021 |
500 |
53,727
(0%)
|
0%
|
139.9 |
69,935
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 136.67 per share. |
01 Nov 2021 |
100 |
54,227
(0%)
|
0%
|
136.7 |
13,667
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
01 Nov 2021 |
2,500 |
17,500
(0%)
|
0%
|
5.5 |
13,625
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
7,625 |
48,704
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
103 |
48,030
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
2,500 |
56,329
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 136.67 per share. |
01 Nov 2021 |
7,625 |
17,500
(0%)
|
0%
|
136.7 |
1,042,109
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. |
01 Nov 2021 |
7,625 |
25,125
(0%)
|
0%
|
5.4 |
41,556
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 136.67 per share. |
01 Nov 2021 |
103 |
17,500
(0%)
|
0%
|
136.7 |
14,077
|
Common Stock |
Stephen Brannan
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
01 Nov 2021 |
103 |
17,603
(0%)
|
0%
|
7.3 |
749
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
2,500 |
10,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 120.72 per share. |
01 Oct 2021 |
2,500 |
0
(0%)
|
0%
|
120.7 |
301,800
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Oct 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 124.17 per share. |
01 Oct 2021 |
1,787 |
39,630
(0%)
|
0%
|
124.2 |
221,892
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 125.17 per share. |
01 Oct 2021 |
3,029 |
27,827
(0%)
|
0%
|
125.2 |
379,140
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 125.18 per share. |
01 Oct 2021 |
8,774 |
30,856
(0%)
|
0%
|
125.2 |
1,098,329
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 123.09 per share. |
01 Oct 2021 |
1,210 |
41,417
(0%)
|
0%
|
123.1 |
148,939
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 121.34 per share. |
01 Oct 2021 |
400 |
42,627
(0%)
|
0%
|
121.3 |
48,536
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 120.13 per share. |
01 Oct 2021 |
600 |
43,027
(0%)
|
0%
|
120.1 |
72,078
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 118.55 per share. |
01 Oct 2021 |
700 |
43,627
(0%)
|
0%
|
118.6 |
82,985
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
08 Sep 2021 |
7,000 |
25,000
(0%)
|
0%
|
9.2 |
64,400
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2021 |
1,900 |
179,725
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2021 |
500 |
181,625
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2021 |
600 |
182,125
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2021 |
7,000 |
182,725
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 120.05 per share. |
08 Sep 2021 |
1,900 |
18,000
(0%)
|
0%
|
120.1 |
228,095
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
08 Sep 2021 |
1,900 |
19,900
(0%)
|
0%
|
9.2 |
17,480
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 120.05 per share. |
08 Sep 2021 |
500 |
18,000
(0%)
|
0%
|
120.1 |
60,025
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
08 Sep 2021 |
500 |
18,500
(0%)
|
0%
|
9.2 |
4,600
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 121.01 per share. |
08 Sep 2021 |
600 |
18,000
(0%)
|
0%
|
121.0 |
72,606
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
08 Sep 2021 |
600 |
18,600
(0%)
|
0%
|
9.2 |
5,520
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 116.16 per share. |
08 Sep 2021 |
7,000 |
18,000
(0%)
|
0%
|
116.2 |
813,120
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 117.82 per share. |
01 Sep 2021 |
2,500 |
0
(0%)
|
0%
|
117.8 |
294,550
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Sep 2021 |
2,500 |
12,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Sep 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 118.62 per share. |
01 Sep 2021 |
3,410 |
47,500
(0%)
|
0%
|
118.6 |
404,494
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 117.87 per share. |
01 Sep 2021 |
1,590 |
50,910
(0%)
|
0%
|
117.9 |
187,413
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 125.51 per share. |
01 Sep 2021 |
2,673 |
44,327
(0%)
|
0%
|
125.5 |
335,488
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 119.52 per share. |
01 Sep 2021 |
500 |
47,000
(0%)
|
0%
|
119.5 |
59,760
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Aug 2021 |
5,000 |
189,725
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
20 Aug 2021 |
5,000 |
18,000
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Steven M. Paul
|
Director, PRESIDENT CEO |
Purchase of securities on an exchange or from another person at price $ 106.10 per share. |
17 Aug 2021 |
1,181 |
108,849
(0%)
|
0%
|
106.1 |
125,304
|
Common Stock |
Steven M. Paul
|
Director, PRESIDENT CEO |
Purchase of securities on an exchange or from another person at price $ 105.63 per share. |
17 Aug 2021 |
1,183 |
107,668
(0%)
|
0%
|
105.6 |
124,960
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 105.83 per share. |
16 Aug 2021 |
100 |
52,500
(0%)
|
0%
|
105.8 |
10,583
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 104.14 per share. |
16 Aug 2021 |
4,021 |
52,600
(0%)
|
0%
|
104.1 |
418,747
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 103.15 per share. |
16 Aug 2021 |
1,379 |
56,621
(0%)
|
0%
|
103.2 |
142,244
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
16 Aug 2021 |
12,500 |
58,000
(0%)
|
0%
|
2.9 |
36,500
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Aug 2021 |
12,500 |
84,917
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
02 Aug 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Aug 2021 |
2,500 |
15,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 114.17 per share. |
02 Aug 2021 |
2,500 |
0
(0%)
|
0%
|
114.2 |
285,425
|
Common Stock |
James I. Healy
|
Director |
Purchase of securities on an exchange or from another person at price $ 117.80 per share. |
02 Jul 2021 |
636 |
636
(0%)
|
0%
|
117.8 |
74,923
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 112.66 per share. |
01 Jul 2021 |
2,500 |
0
(0%)
|
0%
|
112.7 |
281,650
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2021 |
2,500 |
17,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Jul 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Heather Preston
|
Director |
Other type of transaction at price $ 0.00 per share. |
24 Jun 2021 |
184 |
6,556
(0%)
|
0%
|
|
-
|
Common Stock |
Christopher J. Coughlin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
Jeffrey M. Jonas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
James I. Healy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
Heather Preston
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
David E. Wheadon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
Denice M. Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2021 |
8,500 |
8,500
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
14 Jun 2021 |
2,248 |
15,248
(0%)
|
0%
|
9.2 |
20,682
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 129.45 per share. |
14 Jun 2021 |
2,248 |
13,000
(0%)
|
0%
|
129.5 |
291,004
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jun 2021 |
352 |
1,253
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jun 2021 |
900 |
1,605
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jun 2021 |
2,248 |
10,031
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 128.40 per share. |
14 Jun 2021 |
352 |
13,000
(0%)
|
0%
|
128.4 |
45,197
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
14 Jun 2021 |
352 |
13,352
(0%)
|
0%
|
9.2 |
3,238
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 132.52 per share. |
14 Jun 2021 |
900 |
13,000
(0%)
|
0%
|
132.5 |
119,268
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
14 Jun 2021 |
900 |
13,900
(0%)
|
0%
|
9.2 |
8,280
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Jun 2021 |
8,334 |
53,834
(0%)
|
0%
|
9.2 |
76,673
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2021 |
8,334 |
270,492
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2021 |
8,333 |
278,826
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2021 |
13,333 |
287,159
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 131.44 per share. |
10 Jun 2021 |
8,334 |
45,500
(0%)
|
0%
|
131.4 |
1,095,421
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 129.33 per share. |
10 Jun 2021 |
8,333 |
45,500
(0%)
|
0%
|
129.3 |
1,077,707
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Jun 2021 |
8,333 |
53,833
(0%)
|
0%
|
9.2 |
76,664
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 123.68 per share. |
10 Jun 2021 |
13,333 |
45,500
(0%)
|
0%
|
123.7 |
1,649,025
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Jun 2021 |
13,333 |
58,833
(0%)
|
0%
|
9.2 |
122,664
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jun 2021 |
4,000 |
21,000
|
-
|
|
-
|
Option (right to buy) |
Laurie J. Olson
|
Director |
Sale of securities on an exchange or to another person at price $ 112.93 per share. |
07 Jun 2021 |
4,000 |
0
(0%)
|
0%
|
112.9 |
451,720
|
Common Stock |
Laurie J. Olson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.86 per share. |
07 Jun 2021 |
4,000 |
4,000
(0%)
|
0%
|
84.9 |
339,440
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Jun 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2021 |
2,500 |
20,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 111.44 per share. |
01 Jun 2021 |
2,500 |
0
(0%)
|
0%
|
111.4 |
278,600
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 110.07 per share. |
10 May 2021 |
7,000 |
13,000
(0%)
|
0%
|
110.1 |
770,490
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 May 2021 |
7,000 |
20,000
(0%)
|
0%
|
9.2 |
64,400
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 May 2021 |
7,000 |
194,925
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 120.00 per share. |
10 May 2021 |
200 |
13,000
(0%)
|
0%
|
120 |
24,000
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 May 2021 |
200 |
13,200
(0%)
|
0%
|
9.2 |
1,840
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 May 2021 |
200 |
194,725
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 110.43 per share. |
10 May 2021 |
5,000 |
45,500
(0%)
|
0%
|
110.4 |
552,150
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 May 2021 |
5,000 |
50,500
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 May 2021 |
5,000 |
300,492
|
-
|
|
-
|
Option (right to buy) |
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
13 Apr 2021 |
75,000 |
1,456,437
(5%)
|
0%
|
|
0
|
Common Stock |
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
13 Apr 2021 |
1,756 |
5,269
(0%)
|
0%
|
|
0
|
Common Stock |
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
13 Apr 2021 |
75,000 |
1,456,435
(5%)
|
0%
|
|
0
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 114.22 per share. |
12 Apr 2021 |
5,000 |
45,500
(0%)
|
0%
|
114.2 |
571,100
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Apr 2021 |
5,000 |
305,492
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
12 Apr 2021 |
5,000 |
50,500
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Apr 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 110.61 per share. |
01 Apr 2021 |
2,500 |
0
(0%)
|
0%
|
110.6 |
276,525
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2021 |
2,500 |
25,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2021 |
2,500 |
22,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Apr 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 120.01 per share. |
01 Apr 2021 |
2,500 |
0
(0%)
|
0%
|
120.0 |
300,025
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Mar 2021 |
5,000 |
50,500
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Mar 2021 |
5,000 |
310,492
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 118.48 per share. |
10 Mar 2021 |
5,000 |
45,500
(0%)
|
0%
|
118.5 |
592,400
|
Common Stock |
Heather Preston
|
Director |
Other type of transaction at price $ 0.00 per share. |
08 Mar 2021 |
572 |
6,372
(0%)
|
0%
|
|
-
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Mar 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2021 |
2,500 |
27,500
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 125.43 per share. |
01 Mar 2021 |
2,500 |
0
(0%)
|
0%
|
125.4 |
313,575
|
Common Stock |
Steven M. Paul
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Feb 2021 |
161,850 |
161,850
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Feb 2021 |
51,650 |
51,650
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Feb 2021 |
66,900 |
66,900
|
-
|
|
-
|
Option (right to buy) |
Stephen Brannan
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Feb 2021 |
51,350 |
51,350
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 119.57 per share. |
16 Feb 2021 |
10,000 |
13,000
(0%)
|
0%
|
119.6 |
1,195,700
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Feb 2021 |
10,000 |
201,925
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
16 Feb 2021 |
10,000 |
23,000
(0%)
|
0%
|
9.2 |
92,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 114.06 per share. |
10 Feb 2021 |
5,000 |
45,500
(0%)
|
0%
|
114.1 |
570,300
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Feb 2021 |
5,000 |
315,492
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Feb 2021 |
5,000 |
50,500
(0%)
|
0%
|
9.2 |
46,000
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 100.00 per share. |
01 Feb 2021 |
2,500 |
0
(0%)
|
0%
|
100 |
250,000
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Feb 2021 |
2,500 |
30,000
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. |
01 Feb 2021 |
2,500 |
2,500
(0%)
|
0%
|
16 |
40,000
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
11 Jan 2021 |
3,572 |
49,072
(0%)
|
0%
|
7.3 |
25,968
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Jan 2021 |
1,428 |
320,492
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Jan 2021 |
3,572 |
12,828
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 105.11 per share. |
11 Jan 2021 |
1,428 |
45,500
(0%)
|
0%
|
105.1 |
150,097
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
11 Jan 2021 |
1,428 |
46,928
(0%)
|
0%
|
9.2 |
13,138
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 105.11 per share. |
11 Jan 2021 |
3,572 |
45,500
(0%)
|
0%
|
105.1 |
375,453
|
Common Stock |
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
08 Jan 2021 |
1,756 |
3,513
(0%)
|
0%
|
|
0
|
Common Stock |
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
08 Jan 2021 |
75,000 |
1,531,435
(5%)
|
0%
|
|
0
|
Common Stock |
Robert Taylor Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
08 Jan 2021 |
75,000 |
1,531,437
(5%)
|
0%
|
|
0
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
08 Jan 2021 |
8,000 |
21,000
(0%)
|
0%
|
9.2 |
73,600
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jan 2021 |
8,000 |
211,925
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 104.49 per share. |
08 Jan 2021 |
8,000 |
13,000
(0%)
|
0%
|
104.5 |
835,920
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Dec 2020 |
2,131 |
12,279
|
-
|
|
-
|
Option (right to buy) |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
29 Dec 2020 |
5,869 |
10,869
(0%)
|
0%
|
9.2 |
53,995
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
29 Dec 2020 |
2,131 |
13,000
(0%)
|
0%
|
9.2 |
19,605
|
Common Stock |
Troy A. Ignelzi
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Dec 2020 |
5,869 |
219,925
|
-
|
|
-
|
Option (right to buy) |
Denice Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Dec 2020 |
25,000 |
25,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Dec 2020 |
5,714 |
0
|
-
|
|
-
|
Option (right to buy) |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
14 Dec 2020 |
5,714 |
5,714
(0%)
|
0%
|
2.9 |
16,685
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 92.64 per share. |
14 Dec 2020 |
5,714 |
0
(0%)
|
0%
|
92.6 |
529,345
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Dec 2020 |
1,429 |
321,920
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Dec 2020 |
12,500 |
97,417
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 94.82 per share. |
10 Dec 2020 |
1,429 |
45,500
(0%)
|
0%
|
94.8 |
135,498
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.20 per share. |
10 Dec 2020 |
1,429 |
46,929
(0%)
|
0%
|
9.2 |
13,147
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 94.82 per share. |
10 Dec 2020 |
3,571 |
45,500
(0%)
|
0%
|
94.8 |
338,602
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. |
10 Dec 2020 |
3,571 |
49,071
(0%)
|
0%
|
7.3 |
25,961
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
10 Dec 2020 |
12,500 |
45,500
(0%)
|
0%
|
2.9 |
36,500
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Dec 2020 |
3,571 |
16,400
|
-
|
|
-
|
Option (right to buy) |
David Wheadon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Dec 2020 |
25,000 |
25,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert T. Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
12 Nov 2020 |
75,000 |
1,606,437
(6%)
|
0%
|
|
0
|
Common Stock |
Robert T. Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
12 Nov 2020 |
1,757 |
1,757
(0%)
|
0%
|
|
0
|
Common Stock |
Robert T. Nelsen
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
12 Nov 2020 |
75,000 |
1,606,435
(6%)
|
0%
|
|
0
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. |
12 Nov 2020 |
5,000 |
5,000
(0%)
|
0%
|
2.9 |
14,600
|
Common Stock |
Atul Pande
|
Director |
Sale of securities on an exchange or to another person at price $ 96.84 per share. |
12 Nov 2020 |
5,000 |
0
(0%)
|
0%
|
96.8 |
484,200
|
Common Stock |
Atul Pande
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Nov 2020 |
5,000 |
5,714
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 103.80 per share. |
10 Nov 2020 |
9,047 |
33,000
(0%)
|
0%
|
103.8 |
939,079
|
Common Stock |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Nov 2020 |
8,334 |
323,349
|
-
|
|
-
|
Option (right to buy) |
Andrew Miller
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Nov 2020 |
8,333 |
331,683
|
-
|
|
-
|
Option (right to buy) |